StreetInsider.com News Articles

Form 3 Hims & Hers Health, Inc. For: Oct 09 Filed by: Franklin Jonathan M

Thu, 15 Oct 2026 16:45:00 -0400

si-local-file:///var/storage/secattach/20261015/27193931.html

Form 4 Hims & Hers Health, Inc. For: Oct 14 Filed by: Boughton Soleil

Thu, 15 Oct 2026 16:45:00 -0400

si-local-file:///var/storage/secattach/20261015/27193933.html

Hims & Hers Health Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Hims & Hers Health, Inc. - HIMS

Thu, 15 Oct 2026 13:47:17 -0400

NEW ORLEANS, Oct. 15, 2026 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until November 2, 2026 to file lead plaintiff applications in a securities class action lawsuit against Hims & Hers Health, Inc. (“Hims” or the “Company”) (NYSE: HIMS), if they purchased or otherwise acquired the Company’s securities between August 4, 2025 and July 29, 2026, inclusive (the “Class Period”). This action is pending in the United States District Court for the Northern District of California.

Get Help

Hims &

Hims & Hers Health Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Hims & Hers Health, Inc. - HIMS

Thu, 15 Oct 2026 13:47:17 -0400

Get Help

Hims &

Form 144 Hims & Hers Health, Inc. Filed by: Boughton Soleil

Wed, 14 Oct 2026 09:44:00 -0400

si-local-file:///var/storage/secattach/20261014/27185193.html

Hims & Hers Health, Inc. Securities Fraud Class Action Result of Deceptive Privacy and Billing Practices and Over 14% Stock Decline - Investors may Contact Lewis Kahn, Esq., at Kahn Swick & Foti, LLC

Wed, 14 Oct 2026 00:14:06 -0400

NEW YORK and NEW ORLEANS, Oct. 13, 2026 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial losses that they have until November 2, 2026 to file lead plaintiff applications in a securities class action lawsuit against Hims & Hers Health, Inc. (“Hims” or the “Company”) (NYSE: HIMS), if they purchased or otherwise acquired the Company’s securities between August 4, 2025 and July 29, 2026, inclusive (the “Class Period”). This action is pending in the

Hims & Hers Health, Inc. Securities Fraud Class Action Result of Deceptive Privacy and Billing Practices and Over 14% Stock Decline - Investors may Contact Lewis Kahn, Esq., at Kahn Swick & Foti, LLC

Wed, 14 Oct 2026 00:14:06 -0400

Hims & Hers to Announce Third Quarter 2026 Financial Results on November 9, 2026

Mon, 12 Oct 2026 16:05:00 -0400

SAN FRANCISCO--(BUSINESS WIRE)-- Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading global health and wellness platform, today announced that it will report third quarter 2026 financial results after the market closes on Monday, November 9, 2026. The company will host a live conference call to discuss the results at 5:00 p.m. ET the same day.

The conference call can be accessed by dialing (833) 461-5787 for U.S. participants and (585) 542-9983 for international participants, referencing meeting ID 461 746 058. A live audio webcast will be available at https://investors.hims.com and

Hims & Hers to Announce Third Quarter 2026 Financial Results on November 9, 2026

Mon, 12 Oct 2026 16:05:00 -0400

Hims & Hers relaunches Juniper as Hers in Australia

Mon, 12 Oct 2026 15:00:41 -0400

Hims & Hers Health (NYSE: HIMS) has rebranded its Australian women's health platform Juniper as Hers, expanding the service to include hair regrowth, menopause and perimenopause, and weight management treatments.

The rebrand follows Hims & Hers' acquisition of Eucalyptus, the parent company of Juniper, which has operated in Australia since 2021. The transition to Hers completes the company's full platform launch in Australia, after the men's health brand Pilot was rebranded as Hims in August.

Under the Hers brand, Australian women will have access to a 24/7 care team, a digital weight management program, and new hair regrowth formulations. The weight management

Hers Launches in Australia, Built to Care for the Whole Woman

Mon, 12 Oct 2026 15:00:00 -0400

Juniper becomes Hers, bringing new treatments spanning hair regrowth, menopause and perimenopause, and comprehensive weight management

SYDNEY--(BUSINESS WIRE)--

Hims & Hers, the leading global health and wellness platform, today announced the official launch of Hers in Australia, bringing its personalised care platform to women nationwide for the first time. The launch introduces first-of-their-kind treatment programs across Hair, Menopause and Perimenopause, and Weight Loss care - backed by women's-only research and 24/7 Care Team access.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261012999242/en/

Hers Launches in Australia, Built to Care for the Whole Woman

Mon, 12 Oct 2026 15:00:00 -0400

Juniper becomes Hers, bringing new treatments spanning hair regrowth, menopause and perimenopause, and comprehensive weight management

SYDNEY--(BUSINESS WIRE)--

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261012999242/en/

HIMS jumps 7% on peptide tailwind but Citi sees 17% downside from here

Fri, 09 Oct 2026 14:21:49 -0400

Investing.com - Hims & Hers Health (NYSE: HIMS) is trading +7.36% at $30.13 on Friday, sharply reversing Thursday's 5.3% slide, as a Washington Post report that the Trump administration is crafting plans to temporarily allow the sale of certain previously restricted peptides overshadowed a cautious analyst reiteration.

The peptide policy development is the primary driver lifting HIMS today. The Washington Post, citing two people familiar with the matter, reported earlier this week that federal health officials are working toward interim rules that would permit sales while permanent regulations are finalized. That prospect lands directly on Hims & Hers' stated growth strategy:

Hims & Hers Health Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Hims & Hers Health, Inc. - HIMS

Thu, 08 Oct 2026 17:10:42 -0400

NEW ORLEANS, Oct. 08, 2026 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until November 2, 2026 to file lead plaintiff applications in a securities class action lawsuit against Hims & Hers Health, Inc. (“Hims” or the “Company”) (NYSE: HIMS), if they purchased or otherwise acquired the Company’s securities between August 4, 2025 and July 29, 2026, inclusive (the “Class Period”). This action is pending in the United States District Court for the Northern District of California.

Get Help

Hims &

Hims & Hers Health Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Hims & Hers Health, Inc. - HIMS

Thu, 08 Oct 2026 17:10:42 -0400

Get Help

Hims &

Truist Securities Reiterates Hold Rating on Hims and Hers (HIMS)

Thu, 08 Oct 2026 04:29:36 -0400

Truist Securities analyst Jailendra Singh reiterated a Hold rating and $32.00 price target on Hims and Hers (NYSE: HIMS).

The analyst comments "Details on GLP-1 Transaction Trends. On a per-day basis, our Truist Card Data indicates GLP-1 billings in September were down 16% M/M (vs August up 1% M/M). On a per-day basis, September GLP-1 transactions were down 11% M/M (vs August down 9% M/ M on a comparable basis). On a transactions-weighted basis, average duration was 1.12 months in September, down from 1.26 months in August. We would note that branded GLP-1 membership counts for the most recent month should

Hims & Hers names former Rivian controller as chief accounting officer

Wed, 07 Oct 2026 16:17:13 -0400

Hims & Hers Health, Inc. (NYSE: HIMS) has appointed Jon Franklin as Chief Accounting Officer, according to a company statement. Franklin will report to Chief Financial Officer Yemi Okupe and oversee the company's accounting organization.

Franklin joins from Rivian, where he served as Vice President and Corporate Controller, managing technical accounting, corporate accounting, and financial reporting. Before Rivian, he spent more than 15 years in PwC's Assurance division, conducting audits for Fortune 500 multinational organizations and emerging companies across consumer products, technology, and financial services.

Franklin holds a Bachelor of Business Administration in Accounting and a Master of Accounting from the University

Hims & Hers Names Jon Franklin as Chief Accounting Officer

Wed, 07 Oct 2026 16:17:00 -0400

Certified Public Accountant and former Rivian corporate controller will lead Hims & Hers accounting organization as the company expands into new specialties and global markets

SAN FRANCISCO--(BUSINESS WIRE)-- Hims & Hers Health, Inc. (NYSE: HIMS), the leading global health and wellness platform, today announced Jon Franklin has joined the company as Chief Accounting Officer. Franklin, a CPA with two decades of technical accounting experience across public accounting and corporate controllership, will oversee the company’s accounting organization, reporting to Chief Financial Officer Yemi Okupe.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261007133997/en/

Hims & Hers Names Jon Franklin as Chief Accounting Officer

Wed, 07 Oct 2026 16:17:00 -0400

Certified Public Accountant and former Rivian corporate controller will lead Hims & Hers accounting organization as the company expands into new specialties and global markets

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261007133997/en/

Form 8-K Hims & Hers Health, Inc. For: Oct 07

Wed, 07 Oct 2026 16:13:00 -0400

si-local-file:///var/storage/secattach/20261007/27161379.html

Hims & Hers Health, Inc. Securities Fraud Class Action Result of Deceptive Privacy and Billing Practices and Over 14% Stock Decline - Investors may Contact Lewis Kahn, Esq., at Kahn Swick & Foti, LLC

Tue, 06 Oct 2026 21:52:47 -0400

NEW YORK and NEW ORLEANS, Oct. 06, 2026 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial losses that they have until November 2, 2026 to file lead plaintiff applications in a securities class action lawsuit against Hims & Hers Health, Inc. (“Hims” or the “Company”) (NYSE: HIMS), if they purchased or otherwise acquired the Company’s securities between August 4, 2025 and July 29, 2026, inclusive (the “Class Period”). This action is pending in the

Hims & Hers Health, Inc. Securities Fraud Class Action Result of Deceptive Privacy and Billing Practices and Over 14% Stock Decline - Investors may Contact Lewis Kahn, Esq., at Kahn Swick & Foti, LLC

Tue, 06 Oct 2026 21:52:47 -0400

Form 4 Hims & Hers Health, Inc. For: Oct 01 Filed by: Okupe Oluyemi

Fri, 02 Oct 2026 16:32:00 -0400

si-local-file:///var/storage/secattach/20261002/27142887.html

Form 4 Hims & Hers Health, Inc. For: Sep 30 Filed by: Boughton Soleil

Fri, 02 Oct 2026 16:32:00 -0400

si-local-file:///var/storage/secattach/20261002/27142888.html

Form 144 Hims & Hers Health, Inc. Filed by: Okupe Oluyemi

Thu, 01 Oct 2026 12:06:00 -0400

si-local-file:///var/storage/secattach/20261001/27134168.html